Falsified and Substandard Drugs: Stopping the Pandemic

Falsified and substandard medicines are associated with tens of thousands of deaths, mainly in young children in poor countries. Poor-quality drugs exact an annual economic toll of up to US$200 billion and contribute to the increasing peril of antimicrobial resistance. The WHO has emerged recently a...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of tropical medicine and hygiene 2019-05, Vol.100 (5), p.1058-1065
Main Authors: Nayyar, Gaurvika M L, Breman, Joel G, Mackey, Tim K, Clark, John P, Hajjou, Mustapha, Littrell, Megan, Herrington, James E
Format: Article
Language:English
Subjects:
Counterfeit Drugs - economics
Drug Resistance
Drugs
Global Health
Health Policy - economics
Health Policy - legislation & jurisprudence
Legislation, Drug
Pandemics
Pharmaceutical industry
Review
Substandard Drugs - adverse effects
Substandard Drugs - economics
World Health Organization
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Falsified and substandard medicines are associated with tens of thousands of deaths, mainly in young children in poor countries. Poor-quality drugs exact an annual economic toll of up to US$200 billion and contribute to the increasing peril of antimicrobial resistance. The WHO has emerged recently as the global leader in the battle against poor-quality drugs, and pharmaceutical companies have increased their roles in assuring the integrity of drug supply chains. Despite advances in drug quality surveillance and detection technology, more efforts are urgently required in research, policy, and field monitoring to halt the pandemic of bad drugs. In addition to strengthening international and national pharmaceutical governance, in part by national implementation of the Model Law on Medicines and Crime, a quantifiable Sustainable Development Goal target and an international convention to insure drug quality and safety are urgent priorities.
ISSN:0002-9637
1476-1645
DOI:10.4269/ajtmh.18-0981